Associated Papers
UGT1A9, UGT2B7, and MRP2 genotypes can predict mycophenolic acid pharmacokinetic variability in pediatric kidney transplant recipients.
Fukuda T et al.
Therapeutic Drug Monitoring, 2012
UGT1A9 -275T>A/-2152C>T polymorphisms correlate with low MPA exposure and acute rejection in MMF/tacrolimus-treated kidney transplant patients.
van Schaik RH et al.
Clinical Pharmacology and Therapeutics, 2009
Select a paper to view details